Miki Nakamura

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

Ryoko Araki, Masahiro Uda, Yuko Hoki et al. · Nature · 2013 · 496 citations

Regenerative Medicine, Induced Pluripotent, Embryonic Stem Cell +13

Remodeling of gp41-C34 Peptide Leads to Highly Effective Inhibitors of the Fusion of HIV-1 with Target Cells We thank Dr. Terrence R. Burke, Jr., NCI, NIH, Frederick, MD 21702-1201, for proofreading the manuscript and providing useful comments. This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Japan Society for the Promotion of Science, and the Japan Health Science Foundation.

Akira Otaka, Miki Nakamura, Daisuke Nameki et al. · Angewandte Chemie International Edition · 2002 · 162 citations

Sc Peptides, Peptide Engineering, Immunology +21

Calcitonin Receptor Signaling Inhibits Muscle Stem Cells from Escaping the Quiescent State and the Niche

Masahiko Yamaguchi, Yoko Watanabe, Takuji Ohtani et al. · Cell Reports · 2015 · 108 citations · Full text

Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis

Norihiko Sakai, Miki Nakamura, Kenneth E. Lipson et al. · Scientific Reports · 2017 · 75 citations · Full text

Evaluation of a high-affinity QCM immunosensor using antibody fragmentation and 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer

Shigeru Kurosawa, Miki Nakamura, Jong‐Won Park et al. · Biosensors and Bioelectronics · 2004 · 70 citations

Engineering, High-affinity Qcm Immunosensor, 2-Methacryloyloxyethyl Phosphorylcholine +9